This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to overlook the biotechnology sector. However, for investors willing to look beyond ...

Find the latest biotech news, including an appointment strengthening the pathway from translational research to new company ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Guggenheim Emerging Outlook: ...

Danaher Corporation delivered slightly better-than-expected annual earnings, with conservative 2026 guidance that likely ...

Soon to implement a state-of-the-art lab, it's part of the college's new biotechnology lab. It’s meant to be an engineering hub set for possible future employees of pharmaceutical giant Eli ...

SAN FRANCISCO, Feb 4 () - Two U. senators this week introduced a bill that would create new rules around the sale of ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

Plants fix 258 billion tons of CO2 in their chloroplasts through photosynthesis every year. For these cell organelles to work properly, they require certain minerals—particularly ions of the metals ...